Drug Profile
TNX 224
Alternative Names: 166-32; Anti-factor D monoclonal antibodyLatest Information Update: 15 Dec 2004
Price :
$50
*
At a glance
- Originator Tanox
- Class Anti-inflammatories; Monoclonal antibodies
- Mechanism of Action Complement factor D inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Reperfusion injury
Most Recent Events
- 14 Dec 2004 Discontinued - Preclinical for Reperfusion injury in USA (unspecified route)
- 27 Jan 2003 TNX 224 is available for licensing [www.tanox.com]
- 28 Aug 2001 New profile